Przegla̜d Gastroenterologiczny最新文献_第10页

Common peritoneal disorders: what the physician should know. 常见腹膜疾病：医生须知。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 Epub Date: 2023-11-22 DOI: 10.5114/pg.2023.133071

Elroy Patrick Weledji

引用次数: 0

A novel stent fixation method for anastomotic leaks after gastrectomy: anchoring of the distal flare to the jejunum by using through-the-scope endoclips. 胃切除术后吻合口漏的新型支架固定方法：使用镜下内夹将远端喇叭口固定在空肠上。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 Epub Date: 2022-11-10 DOI: 10.5114/pg.2022.121045

Serdar Şenol, Dursun Burak Özdemir

{"title":"A novel stent fixation method for anastomotic leaks after gastrectomy: anchoring of the distal flare to the jejunum by using through-the-scope endoclips.","authors":"Serdar Şenol, Dursun Burak Özdemir","doi":"10.5114/pg.2022.121045","DOIUrl":"10.5114/pg.2022.121045","url":null,"abstract":"Introduction: An anastomotic leak is a life-threatening complication after gastrectomy. A fully covered, self-expandable, metal stent (FC-SEMS) can be used as an alternative to traditional surgical re-intervention. However, stent migration can be worrisome.Aim: To evaluate the feasibility and effectiveness of anchoring of the distal flare of the FC-SEMS to the jejunum by using through-the-scope (TTS) endoclips to prevent stent migration.Material and methods: Patients, who received a FC-SEMS capable of being fixed to the jejunum by using TTS endoclips due to an anastomotic leak after gastrectomy, were reviewed retrospectively. Demographic and clinical characteristics, the properties of the deployed stents, and outcomes were evaluated.Results: A total of 7 patients underwent FC-SEMS placement. The mean age was 59 ±13.8 years, and the mean body mass index was 29.8 ±8.4 kg/m2. All patients' American Society of Anesthesiologists scores were between II and IV. The mean time between gastrectomy and stent insertion was 6.7 ±6.1 days. Technical success was achieved in all patients. Stent migration was not observed in any of the patients. All but one were removed between 4 and 6 weeks after placement. The mean stent removal time was 37 ±4.6 days. Complete resolution of the leak was achieved in 6 patients.Conclusions: Anchoring of the distal flare of the FC-SEMS to the jejunum with TTS endoclips is feasible and may reduce the risk of migration. This inexpensive and safe technique may be proposed to patients with factors predictive of FC-SEMS migration.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"1 1","pages":"416-420"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70475093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Stent insertion for malignant hilar obstruction: a meta-analysis of percutaneous versus endoscopic approaches 支架置入治疗恶性肝门梗阻：经皮与内窥镜入路的荟萃分析

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-11-30 DOI: 10.37766/inplasy2022.11.0156

G. Wang, Yu Fu, Yanyan Yu

引用次数: 0

An unusual cause of abdominal pain 引起腹痛的不寻常原因

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-05-19 DOI: 10.5114/pg.2022.116390

Wiktoria Feret, Katarzyna Gaweł, Patrycja Krynicka, Teresa Starzyńska, W. Marlicz, Wojciech Poncyljusz

{"title":"An unusual cause of abdominal pain","authors":"Wiktoria Feret, Katarzyna Gaweł, Patrycja Krynicka, Teresa Starzyńska, W. Marlicz, Wojciech Poncyljusz","doi":"10.5114/pg.2022.116390","DOIUrl":"https://doi.org/10.5114/pg.2022.116390","url":null,"abstract":"Gastroent Question: An 88year-old woman was admitted to our hospital complaining of upper abdominal and back pain. She had a history of hypertension. On admission, she was febrile with a temperature of 38.4 C, blood pressure was 122/54 mmHg, and her pulse rate was 84 beats per minute. Her abdomen was soft, nondistended, and nontender. Admission blood work revealed a white blood cell count of 7,800/mm. Her liver panel showed a total bilirubin of 1.1 mg/dL (normal, 0.1-1.1); alanine aminotransferase, 62 IU/L (normal, 3-49); aspartate aminotransferase, 47 IU/L, (normal, 9-37); alkaline phosphatase, 438 IU/L, (normal, 104-338); and g-glutamyl transpeptidase, 168 IU/L (normal, 671). Tumor markers were normal: carcinoembryonic antigen, 2.4 ng/mL (normal, <5.0) and carbohydrate antigen 19-9, 17 U/mL (normal, <37). To evaluate further the abnormal liver enzymes, abdominal ultrasound followed by a contrastenhanced CT of the abdomen was performed (Figure A). Side-viewing endoscope showed duodenal papilla (Figure B). What are the findings of the abdominal CT and side-viewing endoscope and what is the diagnosis? See the Gastroenterology web site (www.gastrojournal.org) for more information on submitting your favorite image to Clinical Challenges and Images in GI.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"17 1","pages":"173 - 174"},"PeriodicalIF":1.3,"publicationDate":"2022-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70474567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

The role of vitamin and microelement supplementation in the treatment of ethanol-induced liver disease. 补充维生素和微量元素在治疗酒精性肝病中的作用。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-01-01 DOI: 10.5114/pg.2022.121820

Artur W Uździcki, Aleksandra Zych, Barbara A Świerad, Marta Wawrzynowicz-Syczewska

引用次数: 1

Clinical and genetic characterization of familial Mediterranean fever among a cohort of Egyptian patients. 家族性地中海热在埃及患者队列中的临床和遗传特征。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-01-01 Epub Date: 2022-08-09 DOI: 10.5114/pg.2022.118595

Mohammed Hussien Ahmed, Omar El Henawy, Eslam Mohamed ElShennawy, Aya Mohamed Mahros

{"title":"Clinical and genetic characterization of familial Mediterranean fever among a cohort of Egyptian patients.","authors":"Mohammed Hussien Ahmed, Omar El Henawy, Eslam Mohamed ElShennawy, Aya Mohamed Mahros","doi":"10.5114/pg.2022.118595","DOIUrl":"https://doi.org/10.5114/pg.2022.118595","url":null,"abstract":"Introduction: Familial Mediterranean fever (FMF) is an autosomal recessive disease with an autoinflammatory nature. It affects mainly Turkish, Armenian, Arab, and Jewish people. The clinical presentation and the development of complication as amyloidosis. Early diagnosis and predilection of disease severity according to gene mutation facilitates adequate treatment and disease control.Aim: To our knowledge, few studies were done to evaluate FMF in lower Egypt.Material and methods: This is a prospective study that was carried out at Kafrelsheikh University Hospital Outpatient Clinic between March 2019 and February 2020. We recruited all patients who came to our outpatient clinic with symptoms suggestive of FMF (recurrent attacks of abdominal pain and fever), and diagnosis of FMF was confirmed by gene study. One hundred and nine patients were included; however, 9 patients refused to participate in the study, so final analysis was done for 100 patients only. Patients also underwent abdominal ultrasound examination for measurement of the spleen longitudinal diameter.Results: E148Q mutant allele was the most encountered mutation in our studied patients at Kafrelsheikh, with a frequency of 31%; the number of attacks was greater in patients with positive family history and in homozygous patients. Most patients required a dose between 1.5 and 3 mg/day.Conclusions: Patients with positive family history and those with homozygous mutation have more attacks with greater severity and higher amyloid deposition. E148Q mutant allele was the most commonly encountered in the studied patients, with a frequency of 31%, followed by M6801 (G/A), which was associated with the highest amyloid A level.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"17 3","pages":"240-244"},"PeriodicalIF":1.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/d2/PG-17-47597.PMC9475472.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40373748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe? 2019冠状病毒病(COVID-19)患者的胃肠道症状是敌是友?

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-01-01 Epub Date: 2021-11-18 DOI: 10.5114/pg.2021.111000

Konrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, Adam Tworek, Grażyna Rydzewska

{"title":"Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?","authors":"Konrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, Adam Tworek, Grażyna Rydzewska","doi":"10.5114/pg.2021.111000","DOIUrl":"https://doi.org/10.5114/pg.2021.111000","url":null,"abstract":"Introduction: Gastrointestinal (GI) symptoms can be considered as a manifestation of coronavirus disease 2019 (COVID-19).Aim: Our study analysed GI symptoms depending on their occurrence, and their possible causes and impact on the course of COVID-19.Material and methods: A retrospective, single-centre assessment of the frequency, risk factors, and impact of GI symptoms in 441 patients with COVID-19.Results: A statistically significant reduction in the length of stay (LOS) (15 days vs. 17 days; p = 0.04), intensive care unit admission (ICU) (16.9% vs. 26.8%; p = 0.02), and need for mechanical ventilation (14.1% vs. 23.4%; p = 0.02) in the group who had experienced GI symptoms before hospitalization was noticed. For comparison, patients who developed GI symptoms during hospitalization had statistically significantly longer LOS (21 days vs. 15 days; p = 0.0001), were more frequently admitted to the ICU (38.1% vs. 18.6%; p = 0.0003), and had a higher need for mechanical ventilation (32.7% vs. 16.2%; p < 0.001). Risk factors for GI symptoms during hospitalization in COVID-19 patients included age, Clostridioides difficile infection, and receiving certain treatment (antibiotics and lopinavir + ritonavir).Conclusions: The GI symptoms that developed before admission to hospital correlated with reduced severity of the course of COVID-19. However, in the group of patients who developed GI symptoms during hospitalization, attention should be paid to concomitant treatment. The use of antibiotics should be limited because they are associated with the deterioration of the course of COVID-19; one of the reasons might be changes in the intestinal microbiome.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"17 3","pages":"219-226"},"PeriodicalIF":1.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b6/26/PG-17-45680.PMC9475485.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40373750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Fibrolamellar hepatocellular carcinoma presenting with early recurrent thrombosis. 纤维层状肝细胞癌表现为早期复发性血栓形成。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-01-01 DOI: 10.5114/pg.2022.121827

Hacer Kundakcioglu, Sabahattin Destek, Zuhal Gucin, Kamuran Cumhur Değer

引用次数: 1

A review of magnetic resonance enterography based Crohn's disease activity indices in paediatric patients. 基于磁共振肠造影的儿童克罗恩病活动性指标综述。

IF 1.3

Przegla̜d Gastroenterologiczny Pub Date : 2022-01-01 Epub Date: 2022-03-24 DOI: 10.5114/pg.2022.114753

Roma B Herman, Paulina Dumnicka, Krzysztof Fyderek

引用次数: 2

Vonoprazan in the management of gastric/peptic ulcers: a systematic review of safety data. 治疗胃/消化性溃疡的沃诺普拉赞：安全性数据的系统回顾。

IF 1.7

Przegla̜d Gastroenterologiczny Pub Date : 2022-01-01 Epub Date: 2022-01-23 DOI: 10.5114/pg.2022.112777

Joaquim Prado P Moraes-Filho, Gerson Domingues, Décio Chinzon, Juliana Leite Soares Guedes, Cláudia Yang Santos, Schlioma Zaterka

{"title":"Vonoprazan in the management of gastric/peptic ulcers: a systematic review of safety data.","authors":"Joaquim Prado P Moraes-Filho, Gerson Domingues, Décio Chinzon, Juliana Leite Soares Guedes, Cláudia Yang Santos, Schlioma Zaterka","doi":"10.5114/pg.2022.112777","DOIUrl":"10.5114/pg.2022.112777","url":null,"abstract":"Introduction: Although potassium-competitive acid blockers (P-CABs) prompted safety concerns when first developed, they ultimately proved to have a favourable safety profile.Aim: To assess the safety of vonoprazan in the management of gastroesophageal reflux disease (GERD), peptic ulcers, or gastroduodenal mucosal lesions induced by chronic use of aspirin or non-steroidal anti-inflammatory drugs (NSAIDs).Material and methods: From March to June 2021, a literature search was conducted using Medline via PubMed, Cochrane library, Lilacs, SciELO, and Centre for Reviews and Dissemination (CRD) electronic databases. After applying the eligibility criteria, 10 studies were included in this review. Of these 10 articles, vonoprazan was used as initial therapy in 6 and as maintenance therapy in 4. Adverse event rates were similar for vonoprazan and proton-pump inhibitors (PPIs).Conclusions: Our findings suggest that vonoprazan is a safe option for the management of erosive oesophagitis, gastric/peptic ulcers, or peptic ulcers induced by chronic use of aspirin or NSAIDs.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":"17 4","pages":"266-273"},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/be/e1/PG-17-46211.PMC9743326.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10353391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0